323 related articles for article (PubMed ID: 8752017)
1. Diazepam versus alprazolam for the treatment of panic disorder.
Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
[TBL] [Abstract][Full Text] [Related]
2. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
Schweizer E; Patterson W; Rickels K; Rosenthal M
Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
[TBL] [Abstract][Full Text] [Related]
4. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
Lydiard RB; Lesser IM; Ballenger JC; Rubin RT; Laraia M; DuPont R
J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
[TBL] [Abstract][Full Text] [Related]
5. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder.
Pecknold J; Luthe L; Munjack D; Alexander P
J Clin Psychopharmacol; 1994 Oct; 14(5):314-21. PubMed ID: 7806686
[TBL] [Abstract][Full Text] [Related]
7. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
Modigh K; Westberg P; Eriksson E
J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
[TBL] [Abstract][Full Text] [Related]
8. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
Ravaris CL; Friedman MJ; Hauri PJ; McHugo GJ
J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152
[TBL] [Abstract][Full Text] [Related]
9. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
[TBL] [Abstract][Full Text] [Related]
11. Adinazolam sustained-release treatment of panic disorder: a double-blind study.
Davidson JR; Beitman B; Greist JH; Maddock RJ; Lewis CP; Sheridan AQ; Carter C; Krishnan KR; Liebowitz MR; Haack DG
J Clin Psychopharmacol; 1994 Aug; 14(4):255-63. PubMed ID: 7962681
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
Charney DS; Woods SW
J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment.
Cowley DS; Roy-Byrne PP; Radant A; Ritchie JC; Greenblatt DJ; Nemeroff CB; Hommer DW
Neuropsychopharmacology; 1995 Apr; 12(2):147-57. PubMed ID: 7779243
[TBL] [Abstract][Full Text] [Related]
14. Issues in the assessment of treatment response in panic disorder with special reference to fluvoxamine.
Ninan PT
J Clin Psychiatry; 1997; 58 Suppl 5():24-31. PubMed ID: 9184624
[TBL] [Abstract][Full Text] [Related]
15. Lorazepam vs. alprazolam in the treatment of panic disorder.
Schweizer E; Pohl R; Balon R; Fox I; Rickels K; Yeragani VK
Pharmacopsychiatry; 1990 Mar; 23(2):90-3. PubMed ID: 2187213
[TBL] [Abstract][Full Text] [Related]
16. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
Pols H; Verburg K; Hauzer R; Meijer J; Griez E
Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
[TBL] [Abstract][Full Text] [Related]
17. Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam.
Roy-Byrne PP; Dager SR; Cowley DS; Vitaliano P; Dunner DL
Am J Psychiatry; 1989 Jul; 146(7):860-5. PubMed ID: 2742010
[TBL] [Abstract][Full Text] [Related]
18. Panic disorder: treatment with valproate.
Woodman CL; Noyes R
J Clin Psychiatry; 1994 Apr; 55(4):134-6. PubMed ID: 8071256
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation of alprazolam after long-term treatment of panic-related disorders.
DuPont RL; Swinson RP; Ballenger JC; Burrows GD; Noyes R; Rubin RT; Rifkin A; Pecknold JC
J Clin Psychopharmacol; 1992 Oct; 12(5):352-4. PubMed ID: 1479053
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]